Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6253 USD | -0.75% | -11.92% | -87.25% |
Mar. 15 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
Mar. 14 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.25% | 2.32M | |
+1.92% | 42.59B | |
+8.36% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.75% | 24.81B | |
-24.19% | 18.17B | |
+28.83% | 12.05B | |
-3.06% | 11.7B | |
+6.96% | 11.1B |
- Stock Market
- Equities
- QNRX Stock
- News Quoin Pharmaceuticals, Ltd.
- Ladenburg Thalmann Starts Quoin Pharmaceuticals at Buy With $2 Price Target